PubMed:32917722 / 0-290
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 32-40 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T2 | 132-152 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
| T3 | 249-265 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 92-95 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T2 | 270-274 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 0-11 | Chemical | denotes | Sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
| T2 | 80-91 | Chemical | denotes | Sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
| T3 | 205-216 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 249-265 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-79 | Sentence | denotes | Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. |
| T2 | 80-266 | Sentence | denotes | Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4 | 0-11 | Chemical | denotes | Sphingosine | MESH:D013110 |
| 5 | 32-42 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 6 | 43-48 | Gene | denotes | spike | Gene:43740568 |
| 7 | 74-78 | Gene | denotes | ACE2 | Gene:59272 |
| 38 | 80-91 | Chemical | denotes | Sphingosine | MESH:D013110 |
| 39 | 132-152 | Disease | denotes | bacterial infections | MESH:D001424 |
| 40 | 205-216 | Chemical | denotes | sphingosine | MESH:D013110 |
| 41 | 249-265 | Disease | denotes | viral infections | MESH:D001102 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-79 | Sentence | denotes | Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. |
| T2 | 80-266 | Sentence | denotes | Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 32-42 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 132-152 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
| T3 | 249-265 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 32-40 | OrganismTaxon | denotes | SARS-CoV | 694009 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065|http://purl.obolibrary.org/obo/UBERON_0000072 |